Related by context. All words. (Click for frequent words.) 75 VEGFR2 inhibitor 74 investigational humanized monoclonal antibody 74 Pralatrexate 73 Seliciclib 73 PNP inhibitor 73 orally bioavailable 73 CDK inhibitor 73 ENMD # 73 selective kinase inhibitor 72 oral prodrug 72 Aurora kinase 72 multi kinase inhibitor 71 mertansine 71 angiogenesis inhibitor 71 proteasome inhibitor 71 PEG SN# 71 liposomal formulation 71 huC# DM4 71 Voreloxin 71 immunomodulator 71 HGS ETR2 71 orally administered inhibitor 71 targeting CD# 70 Sapacitabine 70 pan HDAC inhibitor 70 seliciclib 70 OXi# 70 JAK1 70 non nucleoside inhibitor 70 Xanafide 70 signal transduction inhibitor 70 PDE4 inhibitor 70 HCV protease 70 OncoVEX GM CSF 70 SAR# [004] 70 selective modulator 70 PXD# 70 mTOR inhibitor 70 Gleevec resistant 69 Factor VIIa 69 nucleoside analog 69 orally dosed 69 MAGE A3 ASCI 69 receptor tyrosine kinase inhibitor 69 ganetespib 69 Carfilzomib 69 IMA# 69 Blinatumomab 69 EZN 69 radiation sensitizer 69 Sym# 69 vascular disrupting agent 69 IMC A# 69 PSMA ADC 69 Epratuzumab 69 IMiDs R 69 R roscovitine 69 polymerase inhibitor 69 Tesetaxel 69 imatinib Gleevec ® 69 humanized anti 69 PDX pralatrexate 69 antibody fragment 69 Aflibercept 69 forodesine 69 HGS ETR1 69 alvespimycin 69 #I TM# 68 HuMax EGFr 68 alpha folate receptor 68 oral proteasome inhibitor 68 pomalidomide 68 novel anticancer 68 humanized monoclonal antibody 68 Hsp# Inhibitor 68 CDK cyclin dependent 68 Tezampanel 68 Aplidin 68 antibody MAb 68 immunomodulating 68 Perifosine 68 investigational oral inhibitor 68 topoisomerase II inhibitor 68 Alocrest 68 kinase inhibitor 68 Pazopanib 68 CD# monoclonal antibody 68 Dasatinib 68 MEK inhibitors 68 polymerase inhibitors 68 Bortezomib 68 seliciclib CYC# 68 HSP# inhibitor 68 alkylating agent 68 erlotinib Tarceva ® 68 vinca alkaloid 68 tyrosine kinase inhibitor 68 NS#/#A protease 68 cyclin dependent kinase inhibitor 68 metaglidasen 68 Enzastaurin 68 androgen independent 68 Dapagliflozin 68 Symadex 68 ADP receptor antagonist 68 BAY #-# 68 anticancer agent 68 OncoVEX 68 Personalized Immunotherapy 68 CD# antibody [001] 67 CR# vcMMAE 67 selective inhibitor 67 highly selective inhibitor 67 oral picoplatin 67 BAL# [001] 67 Traficet EN 67 humanized antibody 67 IRX 2 67 Tarceva TM 67 MKC# MT 67 selective antagonist 67 histone deacetylase HDAC inhibitor 67 oncolytic 67 mapatumumab 67 Panzem R NCD 67 protein kinase inhibitor 67 MGCD# [001] 67 sphingosine 1 67 solithromycin 67 CCR9 67 Tyrima 67 Elvitegravir 67 AKT inhibitor 67 Panzem 67 Talactoferrin 67 PI3K inhibitor 67 novel immunomodulatory 67 virus HCV protease inhibitor 67 potent anticancer 67 Romidepsin 67 peripherally acting 67 JAK3 67 novel peptide 67 milatuzumab 67 novel topoisomerase 67 PSN# [002] 67 Zolinza 67 Neuvenge 67 sunitinib Sutent ® 67 Bezielle 67 Aurora Kinase 67 anti leukemic 67 Elotuzumab 67 SERMs 67 peptibody 67 potent inhibitor 67 small molecule Hedgehog 67 antibody MT# 67 Omacetaxine 67 anticancer compound 67 investigational pan BCR 67 thymalfasin 67 immunostimulatory 67 Talabostat 67 histone deacetylase inhibitor 67 IAP inhibitor 67 INCB# [001] 67 Nanobody 67 targeted antifolate 67 cetuximab Erbitux R 67 JAK inhibitor 67 Luteinizing Hormone Releasing Hormone 67 Ofatumumab 67 inhaled formulation 67 Virulizin ® 67 Hsp# inhibitors 67 sodium glucose cotransporter 67 FGFR 67 EGFr 67 fosbretabulin 66 PEGylated Fab fragment 66 CYP#A# CYP#D# 66 irreversible inhibitor 66 AEG# 66 ON #.Na 66 CYT# potent vascular disrupting 66 obatoclax 66 CCR5 antagonist 66 pertuzumab 66 GV# [001] 66 CCX# 66 GRN#L 66 vascular disrupting agents 66 Archexin 66 XmAb# 66 systemically administered 66 rNAPc2 66 OMP #M# 66 Aplidin R 66 chimeric monoclonal antibody 66 Epidermal Growth Factor Receptor 66 selective inhibition 66 Cloretazine ® 66 DAVANAT 66 evaluating tivozanib 66 immunomodulatory 66 ALK inhibitor 66 antiangiogenic activity 66 vidofludimus 66 myelofibrosis polycythemia vera 66 somatostatin analogue 66 cMET 66 CCR9 antagonist 66 potent antiproliferative 66 Panzem R 66 YONDELIS 66 K ras mutations 66 dasatinib Sprycel 66 PI3K/Akt pathway inhibitor 66 axitinib 66 anti EGFR antibody 66 dasatinib Sprycel ® 66 Maribavir 66 epothilones 66 BZL# 66 anti amnesic 66 polysaccharide polymer 66 XL# inhibits 66 OMP #R# 66 investigational immunotherapy 66 Oritavancin 66 immune stimulatory 66 generation Hsp# inhibitor 66 DXL# 66 Angiolix 66 sorafenib Nexavar 66 chemokine receptor 66 potent topoisomerase II 66 depsipeptide 66 LY# [003] 66 IMC #B 66 Thiovir 66 ESBA# 66 targets Galectin receptors 66 Golimumab 66 investigational monoclonal antibody 66 HQK 66 TLR9 agonist 66 EGFR HER2 66 Annamycin 66 favorable pharmacokinetic profile 66 Irinotecan 66 replicon 66 Amrubicin 66 accumulate preferentially 66 small molecule tyrosine 66 antitumor 66 MLN# 66 Tarvacin 66 MT# MEDI 66 neuraminidase inhibitor 66 pharmacokinetic interactions 66 delafloxacin 66 HDAC inhibitor 66 HCV protease inhibitor 66 Azedra 66 IgG1 monoclonal antibody 66 HER1 66 epothilone 66 oral antiviral 66 cancer immunotherapies 66 Aurora kinase inhibitor 66 chemopreventive agent 66 selective agonist 66 rhIL 7 65 Glufosfamide 65 adecatumumab 65 small molecule inhibitor 65 Angiocept 65 anti CD# antibody 65 Telintra 65 Proxinium TM 65 selectively inhibit 65 HCV NS3 protease 65 cyclin dependent kinase CDK 65 protein tyrosine phosphatase 1B 65 generation antisense inhibitor 65 sorafenib tablets 65 Pertuzumab 65 GMX# 65 anti proliferative 65 Daclizumab 65 CD# CEA 65 FOLOTYN ® 65 MyVax R 65 EGF receptor 65 galiximab 65 potently inhibit 65 CBLC# 65 Trastuzumab 65 proteasome inhibitors 65 HuMax CD# 65 IL# PE#QQR 65 romidepsin 65 bevacizumab Avastin R 65 SPRYCEL ® 65 trastuzumab DM1 T DM1 65 Cloretazine R 65 Panzem NCD 65 MEK Inhibitor 65 Granulocyte Colony Stimulating Factor 65 GAP #B# 65 PKC# 65 pegylated 65 Phase 2b Clinical Trial 65 compound perifosine 65 CD4 monoclonal antibody 65 nilotinib Tasigna ® 65 DermaVir Patch 65 generation purine nucleoside 65 refractory chronic lymphocytic 65 anticancer activity 65 selectively inhibits 65 MCSP respectively 65 novel VDA molecule 65 XL# anticancer compounds 65 2 methoxyestradiol 65 pro angiogenic 65 AAG geldanamycin analog 65 Linaclotide 65 thalidomide Thalomid 65 Trofex TM 65 MET VEGFR2 65 cilengitide 65 VEGF inhibitors 65 PRT# 65 nilotinib Tasigna 65 enzastaurin 65 XL# XL# 65 imatinib Gleevec 65 small molecule chemotherapeutic 65 drug conjugate 65 ZK EPO 65 CTLA 4 65 vorinostat 65 Presents Preclinical Data 65 Kinase Inhibitor 65 PI3K Akt 65 carbohydrate polymer 65 HCD# [002] 65 phosphate S1P 65 radiolabeled 65 HER3 65 cytoprotective 65 NEUGENE 65 BCR ABL 65 panitumumab Vectibix 65 Aptivus ® 65 hypoxia activated prodrug 65 Vicinium TM 65 HuMax CD4 65 ixabepilone 65 Factor Receptor 65 MGd 65 Pathway Inhibitor 65 TELINTRA 65 NS5B polymerase 65 intranasal formulation 65 Phase Ib study 65 MEK inhibitor 65 Akt inhibitor 65 docetaxel Taxotere ® 65 targeted radiotherapeutic 65 PRTX 65 Metastatic Melanoma 65 teriflunomide 65 INT# [002] 65 ErbB3 65 autologous cellular immunotherapy 65 PEGylated 65 huN# DM1 65 T#I mutant 65 dihydrofolate reductase 65 Atiprimod 65 potent inhibition 65 HCV replicon 65 VEGFR2 65 Solazed TM 65 MYDICAR ® 65 antiangiogenesis 65 leukemia CLL 65 Liposomal 65 factor G CSF 64 hA# 64 Upregulation 64 NU# direct 64 non nucleoside 64 5alpha reductase 64 intravenously administered 64 Vicriviroc 64 Cloretazine 64 5 HT2A inverse 64 Antitumor Activity 64 JAK2 inhibitor 64 cytolytic 64 REP# 64 nucleoside analogues 64 tubulin inhibitor 64 Thiarabine 64 cyclin dependent kinases CDKs 64 IMiDs ® 64 Ambrisentan 64 IMiDs ® compound 64 brostallicin 64 investigational antibody 64 oxidative stress inducer 64 Preclinical studies suggest 64 Ceflatonin 64 anti CD# monoclonal 64 Quinamed 64 Anticalin R 64 NS4A 64 Alfacell proprietary ribonuclease 64 CCR2 64 5 HT2A serotonin 64 R#/MEM # 64 mGluR5 NAM 64 antisense oligonucleotide 64 E#F# 64 IMGN# 64 HDAC Inhibitor 64 enzyme inhibitor 64 MTP inhibitor 64 AMN# [001] 64 #ME# 64 humanized monoclonal 64 Zorbtive TM 64 Telatinib 64 APOPTONE 64 JVRS 64 ISF# 64 S/GSK# 64 binds selectively 64 phase IIb clinical 64 eltrombopag 64 Temsirolimus 64 Tumour Vascular Disrupting Agent 64 GVAX ® 64 antiangiogenic 64 Cannabinor 64 docetaxel Taxotere R 64 therapeutic monoclonal antibody 64 Orally administered 64 MET amplification 64 trastuzumab Herceptin 64 entinostat 64 preclinically 64 Fc fusion protein 64 MAb 64 Etoposide 64 mGluR5 negative 64 CD3 monoclonal antibody 64 Apoptone 64 Humanized Anti 64 Tarvacin TM 64 relapsed multiple myeloma 64 SAR# [002] 64 ATL# [001] 64 PTP 1B 64 Triolex 64 antiproliferative effects 64 receptor inhibitor 64 immune modulator 64 AVE# 64 BiTE ® 64 selective orally bioavailable 64 oral kinase inhibitor 64 oral nucleoside analogue 64 Valortim R 64 RGB # 64 5 FU leucovorin 64 THR beta agonist 64 Erlotinib 64 zanolimumab 64 lenalidomide Revlimid R 64 pan histone deacetylase 64 novel histone deacetylase 64 selective androgen receptor modulator 64 partial agonist 64 eniluracil 64 Vidofludimus 64 hormone LHRH antagonist 64 velafermin 64 alefacept 64 Selective Inhibitor 64 Pivotal Phase III 64 Ad5FGF 4 64 Azacitidine 64 LY# [002] 64 L Annamycin 64 isoform selective 64 MKC# MKC# PP 64 Pharmacokinetics PK 64 BiTE antibody 64 GRNVAC1 64 ZOLINZA 64 oral JAK1 64 peptide antigens 64 tanespimycin 64 TRX1 64 small molecule activators 64 TO AVOID PREGNANCY WHILE 64 immunomodulatory properties 64 EndoTAG TM -1 64 monoclonal antibody IgG1 Mab 64 JAK inhibitors 64 crizotinib PF # 64 MT#/MEDI-# 64 elacytarabine 64 TBC# 64 IGF 1R 64 CTAP# Capsules 64 Interferon alpha 64 Aliskiren 64 Pegloticase 64 AQ4N 64 XYOTAX TM 64 VEGF receptor 64 NXL# 64 aflibercept VEGF Trap 64 octreotide acetate 64 HCV polymerase 64 anti CD3 64 anti angiogenic 64 Deforolimus 64 EGFR tyrosine kinase inhibitors 64 Vandetanib 64 oxaliplatin Eloxatin 64 EGFR TKI 64 IMPDH inhibitor 64 SCCHN 64 M2 subunit 64 KSP inhibitor 64 cleavable linker 64 proprietary polysaccharide 64 RNAi therapeutic targeting 64 Phase #b/#a clinical 64 radezolid 64 BRIM2 64 polyglutamate 64 antitumor activity 64 Protein Kinase C 64 TRAIL R2 64 BiTE 64 AP# [003] 64 luteinizing hormone releasing 64 IAP inhibitors 64 CA4P 64 MVA BN R 64 Smac mimetic 64 cannabinor 64 multikinase inhibitor 64 ENMD 64 BRAF inhibitor 64 mitogen activated ERK kinase 64 ZACTIMA 64 selective inverse agonist 64 interferon lambda 64 xenograft models 64 VitiGam 64 apoptosis inducer 64 GLYX 64 Xeloda ® 64 bispecific 64 IL #E 64 systemic RNAi therapeutic 64 granisetron 64 LEP ETU 64 PARP inhibitor 64 compound AEZS 64 nucleoside analogue 63 interleukin IL -# 63 FLT3 63 HDAC 63 integrase inhibitor 63 Trofex 63 Sphingomab 63 stable nucleic acid 63 ABL inhibitor 63 Pemetrexed 63 INCB# [002] 63 hypoxia inducible factor 63 talabostat 63 T#I [002] 63 BRAF inhibitors 63 LHRH receptor positive 63 belinostat 63 cetuximab Erbitux 63 AMPA kainate 63 pharmacodynamic properties 63 PI3K inhibitors 63 immunotherapeutic 63 triggers apoptosis programmed 63 small molecule thrombopoietin 63 leukemia AML 63 histone deacetylase HDAC 63 highly immunogenic 63 insulin sensitizing 63 MET RET 63 Phase #b/#a trial 63 Bafetinib 63 Camptosar ® irinotecan 63 demonstrated antitumor activity 63 Sudhir Agrawal D.Phil 63 Kahalalide F 63 cediranib 63 Onconase 63 Degarelix 63 PANVAC VF 63 amrubicin 63 uric acid lowering 63 phosphatidylserine PS targeting 63 DNA intercalator 63 gefitinib Iressa 63 Telbivudine 63 anti angiogenic agent 63 PI3K/mTOR 63 bendamustine 63 nucleoside reverse transcriptase inhibitor 63 selective adenosine 63 immunotoxin 63 BRAF kinase 63 anti androgen 63 FOLFOX6 63 VNP#M 63 ritonavir boosted 63 Curaxin CBLC# 63 mu opioid receptor antagonist 63 ANG# 63 Multimeric 63 hematological cancers 63 nab paclitaxel 63 serine protease 63 Guanilib 63 TKB# 63 Virulizin R 63 Phase 2a Clinical Trial 63 mTOR inhibitors 63 poly ADP ribose polymerase 63 Leukine ® 63 IMiD 63 HGS# 63 thrombin receptor 63 TNFa 63 oral isoform selective HDAC 63 NS5b 63 RAF kinase 63 pharmacologically active isomer 63 Reverset 63 Taxotere chemotherapy 63 Fx #A 63 lipoglycopeptide 63 drug pipeline TAFA# 63 Denufosol 63 ATL/TV# 63 veltuzumab 63 microtubule targeting 63 TG# [003] 63 Pegylated 63 HGS ETR1 mapatumumab 63 orally absorbed 63 Randomized Phase 63 EpCAM 63 antiangiogenic agent 63 soluble tumor necrosis 63 CYT# 63 oral ghrelin agonist 63 cetuximab Erbitux ® 63 ImmunoVEX HSV2 63 Ozarelix 63 paclitaxel Taxol ® 63 immunoregulatory 63 epigenetic therapies 63 Romiplostim 63 oral ridaforolimus 63 anti fibrotic 63 IL 1beta 63 hematological malignancies 63 novel tubulin binding 63 CLORETAZINE TM VNP#M 63 TOCOSOL Camptothecin 63 ZD# [001] 63 XL# XL# XL# 63 ALN TTR 63 selective serotonin 2C receptor 63 TLR7 agonist 63 Combination REOLYSIN R 63 trastuzumab Herceptin R 63 substrates inhibitors 63 Omacetaxine mepesuccinate 63 Afatinib 63 Laquinimod 63 Radezolid 63 chemotherapeutic drug 63 REMUNE R 63 mTOR mammalian target 63 Marqibo TM 63 sapacitabine 63 hypoxia selective 63 alpha antagonist 63 triphendiol 63 perifosine 63 Phase Ib II 63 N acetylgalactosamine 6 63 Maxy G# 63 MUC1 63 long acting muscarinic 63 Triapine R 63 Anticalins ® 63 retapamulin 63 tigecycline 63 PROVENGE sipuleucel T 63 neratinib 63 idarubicin 63 TKM ApoB 63 telomerase inhibitor 63 Bavituximab 63 activin 63 Crizotinib 63 immune modulating 63 Lenocta TM sodium stibogluconate 63 pegylated interferons 63 5 fluorouracil leucovorin 63 developing Bicifadine serotonin 63 orally inhaled 63 tipifarnib 63 JAK2 inhibitors 63 oncolytic viruses 63 RAS MAPK pathway 63 TPO receptor 63 paclitaxel Taxol 63 Exherin TM 63 Presents Preclinical 63 vWF 63 mTOR pathway 63 HER2/neu 63 EndoTAG 63 serine threonine kinase 63 castration resistant prostate cancer 63 leading oral taxane 63 PEGylated anti 63 antitumor effect 63 Methylnaltrexone 63 Meets Primary Endpoint 63 Ixabepilone 63 torezolid 63 Preclinical Study 63 CoFactor 63 Imprime PGG 63 HER2 receptor 63 thymidylate synthase TS 63 intravesical infusion therapy 63 Abiraterone acetate 63 telomerase therapeutic 63 injectable formulation 63 tyrosine kinase inhibitor TKI 63 EGFR pathway 63 reversible inhibitor 63 Civacir 63 LHRH antagonist 63 Abiraterone 63 R sorafenib tablets 63 Tß4 63 beta 1a 63 Eculizumab 63 orally bioavailable mimics 63 adalimumab Humira 63 Chemokine Receptor 63 antiproliferative 63 tumor xenograft models 63 cytostatic 63 OncoVex 63 pharmacodynamic profile 63 novel prodrug 63 amifostine 63 anionic backbone 63 novel emulsion formulation 63 Herceptin trastuzumab 63 sapacitabine CYC# 63 sunitinib malate 63 induce apoptosis 63 ErbB3 HER3 63 TRAIL induced apoptosis 63 TRO# 63 Flt3 63 Lenalidomide 63 Milatuzumab 63 delta opioid receptor 63 immunotherapeutic agent 63 Safinamide 63 p# mitogen activated 63 lapatinib Tykerb 63 agonistic human 63 tezampanel 63 corticosteroid dexamethasone 63 decitabine 63 atacicept 63 small molecule activator 63 Cutaneous T 63 Epothilone D 63 oral dihydropyrimidine dehydrogenase DPD 62 aurora kinase 62 adecatumumab MT# 62 molecularly targeted 62 VEGF receptors 62 C5aR 62 selective estrogen receptor 62 thymidylate synthase 62 gemcitabine Gemzar 62 CEQ# 62 Epothilones 62 D aspartate NMDA receptor 62 R roscovitine CDK cyclin 62 Ramoplanin 62 thrombopoietin 62 EGFR inhibitors 62 relapsed ovarian cancer 62 ocular formulation 62 hyaluronidase enzyme 62 BiTE R 62 Gefitinib 62 xanthine oxidase inhibitor 62 daptomycin 62 tyrosine kinase inhibitors 62 DACH platinum 62 apoptosis proteins 62 relapsed refractory multiple myeloma 62 flavopiridol 62 antithrombotic 62 Anidulafungin 62 TMC# [002] 62 lipopeptide 62 Boceprevir 62 receptor antagonists 62 reverse transcriptase inhibitors 62 Curaxin 62 tiapamil 62 azacytidine 62 androgen receptor AR 62 antimitotic 62 DU #b 62 CCR1 62 trabectedin 62 elotuzumab 62 Bevacizumab 62 peptidic compound 62 Preclinical Data 62 Histone deacetylase 62 potent suppressor 62 class anticancer quinolone 62 Hsp# inhibition 62 indibulin 62 riociguat 62 Akt activation 62 BCR ABL inhibitors 62 NVA# 62 investigational oral 62 potently inhibited 62 lorvotuzumab mertansine 62 Aurexis 62 cangrelor 62 metastatic colorectal 62 small molecule glucokinase 62 LymphoStat B belimumab 62 Oral NKTR 62 pralatrexate 62 liposomal doxorubicin 62 factor Xa 62 microtubule inhibitor 62 cutaneous T cell 62 lintuzumab 62 Nanobody ® 62 UPLYSO 62 novel orally administered 62 Diffuse Large B 62 selectively inhibited 62 immune modulators 62 tubulin binding 62 estramustine 62 MYCAMINE 62 promoter methylation 62 RhuDex ® 62 BNC# 62 cortisol synthesis 62 Interferon alpha 2b 62 PI3 kinase 62 T DM1 62 Vorinostat 62 TNFα 62 5 HT6 62 chemotherapy induced neutropenia 62 torezolid phosphate 62 Neulasta ® 62 PPARgamma 62 relapsed leukemia 62 IGF1R 62 kinase inhibition 62 oral Janus kinase 62 HuLuc# 62 fusion inhibitor 62 erlotinib Tarceva 62 GM CSF 62 TREANDA 62 maturation inhibitor 62 GM CSF granulocyte 62 AVN# [001] 62 PDGFR 62 antitumoral 62 Pradefovir 62 essential thrombocythemia ET 62 immunomodulatory therapy 62 antifibrotic 62 Vidaza ® 62 Angiolix R 62 Resten NG 62 immunoconjugate 62 Ophena TM 62 SCH # 62 nucleotide analog 62 ErbB 62 endothelin receptor 62 Cleviprex TM clevidipine 62 HDACi 62 HER2 ErbB2 62 VP# [004] 62 generation nucleoside analog 62 Capecitabine 62 multitargeted 62 NeoLipid R 62 Albuferon TM 62 Rigel R# 62 Doxorubicin 62 Ocrelizumab 62 NS5A 62 HER2 positive metastatic breast 62 Eg5 62 Everolimus 62 heparanase 62 Taxotere docetaxel 62 EGFR tyrosine kinase inhibitor 62 Reolysin 62 MDV# 62 monoclonal antibody 62 Belimumab 62 HCV NS5B polymerase 62 #beta HSD1 62 orally administered 62 cell lymphoma CTCL 62 5 HT2A receptor 62 dasatinib 62 Hsp# inhibitor 62 bevacizumab Avastin ® 62 mTOR kinase 62 non nucleoside HCV 62 synthetic peptide 62 NNRTIs 62 antisense inhibitors 62 Anti Tumor 62 Ganciclovir 62 histone deacetylase inhibitors 62 imetelstat 62 vinca alkaloids 62 bortezomib Velcade 62 dose escalation clinical 62 OvaRex R 62 ARIKACE 62 humanised monoclonal antibody 62 castrate resistant prostate cancer 62 Bruton tyrosine kinase 62 goserelin 62 JAK Inhibitor 62 refractory multiple myeloma 62 Mipomersen 62 induces apoptosis 62 gastrointestinal stromal tumors GISTs 62 Antiangiogenic 62 anti secretory 62 CXB# 62 Zoraxel TM 62 gemcitabine Gemzar ® 62 sulindac 62 P2Y 62 Azixa 62 candidate deforolimus 62 IMP# 62 secretory phospholipase A2 62 chemotherapeutic agent 62 GW# [003] 62 endostatin